Case Report: Respiratory paralysis associated with polymyxin B therapy
Polymyxin B (PMB) and colistin are bactericidal polypeptide antibiotics discovered in 1947 and 1949 for the treatment of gram-negative bacterial infections. Polymyxin was used clinically in the 1950s, but it was gradually replaced by other antibiotics in the 1980s because of its high nephrotoxicity...
Main Authors: | Yachan Ning, Yanqi Chu, You Wu, Ying Huang, Chunmei Wang, Li Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.963140/full |
Similar Items
-
Review of the international consensus guidelines for the optimal use of the polymyxins
by: Eliseeva E.V., et al.
Published: (2019-12-01) -
Polymyxin-induced neuromuscular weakness: a case report
by: Amanda X. Y. Chin, et al.
Published: (2024-03-01) -
Polymyxins: To Combine or Not to Combine?
by: Federico Perez, et al.
Published: (2019-04-01) -
Induction and nosocomial dissemination of carbapenem and polymyxin-resistant Klebsiella pneumoniae
by: Gilberto Gambero Gaspar, et al.
Published: (2015-01-01) -
Molecular mechanisms of polymyxin resistance and detection of mcr genes
by: Patrik Mlynarcik, et al.
Published: (2019-02-01)